Prevalence of acute toxicity in gynecological brachytherapy at a reference center in oncology
DOI:
https://doi.org/10.21527/2176-7114.2026.51.16261Keywords:
brachytherapy, genital neoplasms, uterine cervical neoplasms, radiation effects, toxicityAbstract
The objective of this study is to analyse the prevalence of acute toxicity in gynecological cancer patients undergoing brachytherapy at a cancer treatment center in Santa Catarina. This was a descriptive, exploratory cross-sectional study with a quantitative approach. Data were collected from electronic medical records from the oncology referral service. The population comprised patients diagnosed with gynecological cancer who started and completed teletherapy followed by brachytherapy from January to December 2022. The total population consisted of 90 women, and the main toxicity reported was grade 0 radiodermatitis, followed by dysuria and diarrhoea. Other toxicities were observed in the gastrointestinal and genitourinary systems, such as nausea, insomnia, decreased appetite, grade I radiodermatitis, fatigue, vaginal discharge, loose stools, and lower abdominal pain. Identifying the toxicity profile of women undergoing radiotherapy assists the multidisciplinary team in patient care and management.
References
1. D’Augè TG, Giannini A, Bogani G, Dio C Di, Laganà AS, Donato V Di, et al. Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives. Vol. 50, Clinical and Experimental Obstetrics and Gynecology. 2023.
2. GloboCAN 2020. Cancer Today - IARC. Https://Gco.Iarc.Fr/Today/Data/Factsheets/Populations/682-Saudi-Arabia-Fact-Sheets.Pdf. 2021.
3. Organização Pan-Americana da Saúde (OPAS), Organização Mundial da Saúde (OMS). Câncer do colo do útero [Internet]. 2025 [cited 2025 Sep 16]. Available from: https://www.paho.org/pt/topicos/cancer-do-colo-do-utero
4. Athanasiou A, Bowden S, Paraskevaidi M, Fotopoulou C, Martin-Hirsch P, Paraskevaidis E, et al. HPV vaccination and cancer prevention. Vol. 65, Best Practice and Research: Clinical Obstetrics and Gynaecology. 2020.
5. Reis R de S, Lima FC da S de, Silva DHN da, Cavalcante JPF, Corrêa F de M, Santos YRP, et al. Infecção por HPV e Controle do Câncer no Brasil: O Importante Papel da Vacinação. Revista Brasileira de Cancerologia. 2025 Feb 3;71(1).
6. Santos AC da S, Silva NNT, da Silva IDCG, Carneiro M, Coura-Vital W, Lima AA. Effectiveness of HPV vaccination in reducing infection among young Brazilian women. BMC Infect Dis. 2025 Dec 1;25(1).
7. Instituto Nacional de Câncer. Danos e números sobre câncer do colo do útero: relatório anual 2022 [Internet]. Rio de Janeiro; 2022 [cited 2025 Sep 16]. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/dados_e_numeros_colo_22novembro2022.pdf
8. Ren H, Jia M, Zhao S, Li H, Fan S. Factors Correlated with the Accuracy of Colposcopy-Directed Biopsy: A Systematic Review and Meta-Analysis. Journal of Investigative Surgery. 2022;35(2).
9. Silva TG da, Oliveira KML de, Morais SCRV, Perreli JGA, Sousa S de MA de, Linhares FMP. Disfunção sexual em mulheres com câncer do colo do útero submetidas à radioterapia: análise de conceito. Escola Anna Nery. 2021;25(4).
10. Valério MP, Amorim NGM, Assis LMF, Campos LS, Pereira GM, Alvarenga NOMS, et al. Câncer de colo de útero: do diagnóstico ao tratamento / Cervical Cancer: From Diagnosis to Treatment. Brazilian Journal of Development. 2022;8(3).
11. Morais LJ de, Monteiro Neto AJ de O, Menezes JLP de, Pereira MGP, Pereira YD, Nóbrega VM da. Qualidade de Vida Associada ao Tratamento com Radioterapia em Mulheres Acometidas pelo Câncer do Colo do Útero: Revisão Integrativa da Literatura. Revista Brasileira de Cancerologia. 2021;67(3).
12. Firmino A do V, Lopes A, Filho PRS. Adesão e associação no controle da diarreia da dieta de baixo resíduo em pacientes com adenocarcinoma de reto na vigência de tratamento neoadjuvante com radioterapia e quimioterapia. BRASPEN J. 2024;39(2).
13. Instituto Nacional de Câncer. Estatísticas de câncer [Internet]. 2025 Apr. Available from: https://www.gov.br/inca/pt-br/assuntos/cancer/numeros/
14. Paulino E, de Melo AC, Silva-Filho AL, Maciel L de F, Thuler LCS, Goss P, et al. Panorama of Gynecologic Cancer in Brazil. JCO Glob Oncol. 2020;(6).
15. Santos J de SR dos, Santos AAP dos, Lucena TS de, Pontes C de O, Santana KGS de, Cavalcante KOR. Perfil das pacientes com câncer de colo uterino atendidas em um centro de oncologia. Revista Eletrônica Acervo Saúde. 2023;23(5).
16. Lima KF de, Melo LHCP, Gomes LM, Rodrigues-Antunes S, Feio DCA. A importância dos fatores associados a não adesão ao exame preventivo do câncer de colo uterino por mulheres brasileiras – revisão sistemática. Revista Brasileira de Análises Clínicas. 2022;54(1).
17. Rozario S do, Silva IF da, Koifman RJ, Silva IF da. Characterization of women with cervical cancer assisted at Inca by histological type. Rev Saude Publica. 2019;53.
18. Instituto Brasileiro de Geografia e Estatística - IBGE. Panorama do Censo 2022:População [Internet]. 2022 [cited 2025 Sep 16]. Available from: https://censo2022.ibge.gov.br/panorama/?utm_source=ibge&utm_medium=home&utm_campaign=portal
19. de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, et al. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicenter, randomised, phase 3 trial. Lancet Oncol. 2016;17(8).
20. Onal C, Yuce Sari S, Yavas G, Oymak E, Birgi SD, Yigit E, et al. Outcome and safety analysis of endometrial cancer patients treated with postoperative 3D-conformal radiotherapy or intensity modulated radiotherapy. Acta Oncol (Madr). 2021;60(9).
21. Faye MD, Alfieri J. Advances in Radiation Oncology for the Treatment of Cervical Cancer. Vol. 29, Current Oncology. 2022.
22. Chassagne D, Dutreix A, Almond P, Burgers JM V., Busch M, Joslin CA. International Commission on Radiation Units and Measurements (ICRU). Dose and volume specification for reporting intracavitary therapy in gynecology. ICRU report 38. Journal of the International Commission on Radiation Units and Measurements. 1985;
23. Pimentel NBL, Modesto FC, Lima VCGS, Andrade KBS de, Oliveira AM de, Fuly P dos SC, et al. O câncer do colo uterino e o impacto psicossocial da radioterapia pélvica: revisão integrativa. Research, Society and Development. 2020;9(10).
24. Feitosa VPC, Carneiro SR, Rodrigues CNC, Teixeira R da C, Latorre GFS, Nunes EFC. Sintomas urinários e a qualidade de vida de mulheres no pós-tratamento de câncer do colo do útero. Fisioterapia Brasil. 2022;23(3).
25. Gonçalves PAM, Cavalcante LL, Matias GP, Pinezi GCD, Nogueira BAC, Chaves LL, et al. Efeitos colaterais sofridos por pacientes submetidas à radioterapia por câncer de colo de útero: uma revisão de literatura. REVISTA FOCO. 2024 Mar 26;17(3):e4731.
26. Contini CLF, Da Silva C, Müller J dos S, Tuono VL, Melo JAC de, Dorow PF. Atuação da enfermagem nos efeitos adversos da radioterapia ginecológica: revisão integrativa. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218. 2025 May 24;6(5):e656435.
27. Shirali E, Yarandi F, Ghaemi M, Montazeri A. Quality of life in patients with gynecological cancers: A web-based study. Asian Pacific Journal of Cancer Prevention. 2020;21(7).
28. Cox JD, Stetz JA, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC). Vol. 31, International Journal of Radiation Oncology, Biology, Physics. 1995.
29. Fan Z, Liang H, Wei X, Cui B, Wang L. Prevention and management of radiodermatitis in patients with brachytherapy for gynecologic neoplasms summary of the evidence. Vol. 15, Frontiers in Oncology. Frontiers Media SA; 2025.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 João Henrique Rodrigues Mehl , Joice Pilger , Charlene da Silva, Juliana dos Santos Müller , Cássila Laís Florêncio Contini , Patrícia Fernanda Dorow, Maurício Mitsuo Monção
This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Revista Contexto & Saúde, authors agree to the following terms:
The works are licensed under the Creative Commons Atribuição 4.0 Internacional (CC BY 4.0) license, which allows:
Share — to copy and redistribute the material in any medium or format;
Adapt — to remix, transform, and build upon the material for any purpose, including commercial.
These permissions are irrevocable, provided that the following terms are respected:
Attribution — authors must be properly credited, with a link to the license and indication of any changes made.
No additional restrictions — no legal or technological measures may be applied that restrict the use permitted by the license.
Notes:
The license does not apply to elements in the public domain or covered by legal exceptions.
The license does not grant all rights necessary for specific uses (e.g., image rights, privacy, or moral rights).
The journal is not responsible for opinions expressed in the articles, which are the sole responsibility of the authors. The Editor, with the support of the Editorial Board, reserves the right to suggest or request modifications when necessary.
Only original scientific articles presenting research results of interest that have not been published or simultaneously submitted to another journal with the same objective will be accepted.
Mentions of trademarks or specific products are intended solely for identification purposes, without any promotional association by the authors or the journal.
License Agreement (for articles published from September 2025): Authors retain copyright over their article and grant Revista Contexto & Saúde the right of first publication.
